DELAYED LOW-DENSITY-LIPOPROTEIN (LDL) CATABOLISM DESPITE A FUNCTIONALINTACT LDL-APOLIPOPROTEIN-B PARTICLE AND LDL-RECEPTOR IN A SUBJECT WITH CLINICAL HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Hhj. Schmidt et al., DELAYED LOW-DENSITY-LIPOPROTEIN (LDL) CATABOLISM DESPITE A FUNCTIONALINTACT LDL-APOLIPOPROTEIN-B PARTICLE AND LDL-RECEPTOR IN A SUBJECT WITH CLINICAL HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, The Journal of clinical endocrinology and metabolism, 83(6), 1998, pp. 2167-2174
We identified a 38-yr-old male patient with the clinical expression of
homozygous familial hypercholesterolemia presenting as severe coronar
y artery disease, tendon and skin xanthomas, arcus lipoides, and joint
pain. The genetic trait seems to be autosomal recessive. Interestingl
y, serum concentrations of cholesterol responded well to diet and stat
ins. We had no evidence of an abnormal low density Lipoprotein (LDL)-a
polipoprotein B (apoB) particle, which was isolated from the patient u
sing the U937 proliferation assay as a functional test of the LDL-bind
ing capacity. The apoB 3500 and apoB 3531 defects were ruled out by PC
R. In addition, we found no evidence for a defect within the LDL-recep
tor by skin fibroblast analysis, linkage analysis, single-strand confo
rmational polymorphism and Southern blot screening across the entire L
DL-receptor gene. The in vivo kinetics of radioiodinated LDL-apoB were
evaluated in the proband and three normal controls, subsequently. The
LDL-apoB isolated from the patient showed a normal catabolism, confir
ming an intact LDL particle. In contrast the fractional catabolic rate
(d(-1)) of autologous LDL in the subject and the normal controls reve
aled a remarkable delayed catabolism of the patient's LDL (0.15 us. 0.
33-0.43 d(-1)). In addition, the elevation of LDL-cholesterol in the p
atient resulted from an increased production rate with 22.8 mg/kg per
day us. 12.7-15.7 mg/kg per day. These data indicate that there is ano
ther catabolic defect beyond the apoB and LDL-receptor gene causing fa
milial hypercholesterolemia.